£128.21

Academic Press Excitatory Amino Acids: Clinical Results with Antagonists

Price data last checked 147 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

This is the usual price. Wait for it to drop, or tell us your number.

£128 today · usual range £0–£0 · best ever £71

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 584 days • 584 data points (No recent data available)

Historical
Generating forecast...
£134.73 £64.36 £79.72 £95.07 £110.42 £125.77 £141.13 09 June 2024 01 November 2024 27 March 2025 20 August 2025 13 January 2026

Price Distribution

Price distribution over 584 days • 4 price ranges

Days at Price
Current Price
324 days 43 days 35 days 182 days · current 0 81 162 243 324 £71-84 £96-109 £109-122 £122-135 Days at Price

Price Analysis

Most common range: £71-84 (324 days, 55.5%)

Price range: £71 - £135

Price levels: 4 price ranges over 584 days

Description

Glutamate is the major excitatory neurotransmitter in the brain and dysfunction of glutamate transmission is the likely cause of a variety of diseases including neurodegeneration following cerebral ischemia, Huntington's chorea, amyotrophic lateral sclerosis, epilepsy, spasticity, emesis, chronic pain, and schizophrenia. Excitatory amino acid receptor agonists and antagonists are therefore of major interest as potential drugs for central nervous system disorders. Excitatory Amino Acids is the first book entirely dedicated to the results of human testing of modulators of excitatory amino acid neurotransmitters. Coverage of the field of excitatory amino acids from synaptic function to preclinical and clinical pharmacology Description of the development of NMDA (Nmethyl-d-aspartate) and non-NMDA antagonists Reports of potential drugs in early and late clinical stages of development Review "This book is intended for research neuroscientists but can be effectively utilized by clinicians and students because of its clarity of style and excellent illustrations... Many excellent diagrams and charts are scattered throughout this volume. They make for easy conceptualization of the results of preclinical as well as phase one and two clinical trials... This book provides a much needed report on these exciting neuroprotective agents, several of which will be released by the FDA in the near future." --Thomas H. Jobe, MD, University of Illinois at Chicago College of Medicine for DOODY'S PUBLISHING REVIEWS Review Selected one of Doody's "250 Best" Health Sciences Books of 1997 Awarded four stars by Doody's Publishing Reviews From the Back Cover Glutamate is the major excitatory neurotransmitter in the brain, and dysfunction of glutamate transmission is the likely cause of a number of different diseases, including neurodegeneration folloiwng cerebral ischemia, Huntington's chorea, amyotrophic lateral sclerosis, epilepsy, sasticity, emesis, chronic pain and schizophrenia. Excitatory amino acid receptor agonists and antagonists are therefore of major interest as potential drugs for central nervous system disorders. Excitatory Amino Acids - Clinical Results with Antagonists is the first book entirely dedicated to the results of human testing of modulators of excitatory amino acid neurotransmitters. Features include: * Coverage of the field of excitatory amino acids from synaptic function to preclinical and clinical pharmacology * Description of the development of NMDA ( Nmethyl- d-aspartate) and non-NMDA antagonists * Reports of potential drugs in early and late clinical stages of development. This book describes future hopes as well as disappointments in one of the most exciting fields of neuroscience and is edited by Paul Herrling, Head of Corporate Research, Sandoz Pharma Ltd, Basle, Switzerland. About the Author Paul L. Herrling is currently Head of Corporate Research at Sandoz Pharmacies in Basel, Switzerland.

Product Specifications

Barcode

No barcode data available

Similar Products You Might Like

Excitotoxicity in Neurological Diseases: New Therapeutic Challenge
97% match

Excitotoxicity in Neurological Diseases: New Therapeutic Challenge

Springer

£110.66 08 Jan 2026
EXCITOTOXICITY FUNDAMENTAL: Fundamental Concepts, Pathophysiology & Treatment Strategies (Neuroscience Research Progress)
96% match

EXCITOTOXICITY FUNDAMENTAL: Fundamental Concepts, Pathophysiology & Treatment Strategies (Neuroscience Research Progress)

£38.76 28 Feb 2026
Humana - The Metabotropic Glutamate Receptors Book
96% match

Humana - The Metabotropic Glutamate Receptors Book

Humana

£113.48 20 Apr 2026
Ionotropic Glutamate Receptors in the CNS: 141 (Handbook of Experimental Pharmacology, 141)
96% match

Ionotropic Glutamate Receptors in the CNS: 141 (Handbook of Experimental Pharmacology, 141)

Springer

£437.00 14 Jan 2026
Ionotropic Glutamate Receptors in the CNS: 141 (Handbook of Experimental Pharmacology, 141)
96% match

Ionotropic Glutamate Receptors in the CNS: 141 (Handbook of Experimental Pharmacology, 141)

Springer

£341.86 30 Jan 2026
Excitatory Amino Acids and Second Messenger Systems: 3 (Ernst Schering Foundation Symposium Proceedings)
96% match

Excitatory Amino Acids and Second Messenger Systems: 3 (Ernst Schering Foundation Symposium Proceedings)

Springer

£76.62 23 Feb 2026
Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)
96% match

Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)

Humana

£104.04 27 Feb 2026
Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)
96% match

Biochemical Approaches for Glutamatergic Neurotransmission: 130 (Neuromethods, 130)

Humana

£80.28 22 Feb 2026
Excitotoxins: Proceedings of an International Symposium held at The Wenner-Gren Center, Stockholm, August 26–27, 1982: 39 (Wenner-Gren Center International Symposium Series)
96% match

Excitotoxins: Proceedings of an International Symposium held at The Wenner-Gren Center, Stockholm, August 26–27, 1982: 39 (Wenner-Gren Center International Symposium Series)

Springer

£77.11 08 Mar 2026
Glutamate Receptors in Peripheral Tissue: Excitatory Transmission Outside the CNS (Endocrine Updates S)
96% match

Glutamate Receptors in Peripheral Tissue: Excitatory Transmission Outside the CNS (Endocrine Updates S)

Springer

£44.48 24 Jan 2026
Glutamate and GABA Receptors and Transporters: Structure, Function and Pharmacology (Pharmaceutical Science Series)
95% match

Glutamate and GABA Receptors and Transporters: Structure, Function and Pharmacology (Pharmaceutical Science Series)

CRC Press

£240.00 23 Jan 2026
Glutamate and Addiction (Contemporary Clinical Neuroscience)
95% match

Glutamate and Addiction (Contemporary Clinical Neuroscience)

Humana

£147.38 10 Mar 2026
Molecular Mechanisms of Neurotransmitter Release (Contemporary Neuroscience)
95% match

Molecular Mechanisms of Neurotransmitter Release (Contemporary Neuroscience)

Humana

£117.65 23 Jan 2026
Nitric Oxide in Brain Development, Plasticity, and Disease (Volume 118) (Progress in Brain Research, Volume 118)
95% match

Nitric Oxide in Brain Development, Plasticity, and Disease (Volume 118) (Progress in Brain Research, Volume 118)

Elsevier

£179.29 08 Jan 2026
Cellular Regulation of Glutamate Receptors in Central Neurons: Intracellular Signaling, Receptor Trafficking, Protease Proteolysis
95% match

Cellular Regulation of Glutamate Receptors in Central Neurons: Intracellular Signaling, Receptor Trafficking, Protease Proteolysis

VDM Verlag

£57.65 13 Jan 2026
Transmitter Molecules in the Brain: Part I: Biochemistry of Transmitter Molecules Part II: Function and Dysfunction: 2 (Basic and Clinical Aspects of Neuroscience, 2)
95% match

Transmitter Molecules in the Brain: Part I: Biochemistry of Transmitter Molecules Part II: Function and Dysfunction: 2 (Basic and Clinical Aspects of Neuroscience, 2)

Springer

£44.50 07 Mar 2026
Wiley Chemical Biology of Neurodegeneration - Molecular Approach
95% match

Wiley Chemical Biology of Neurodegeneration - Molecular Approach

Wiley

£135.00 26 Feb 2026
Synaptosomes: 141 (Neuromethods, 141)
95% match

Synaptosomes: 141 (Neuromethods, 141)

Humana

£103.26 12 Dec 2025
The Glutamate Synapse as a Therapeutic Target (Volume 116) (Progress in Brain Research, Volume 116)
95% match

The Glutamate Synapse as a Therapeutic Target (Volume 116) (Progress in Brain Research, Volume 116)

Elsevier

£148.39 10 Mar 2026
NMDA Receptors: Methods and Protocols: 2799 (Methods in Molecular Biology, 2799)
95% match

NMDA Receptors: Methods and Protocols: 2799 (Methods in Molecular Biology, 2799)

Humana

£134.00 02 Apr 2026
Dopamine - Glutamate Interactions in the Basal Ganglia: 49 (Frontiers in Neuroscience)
95% match

Dopamine - Glutamate Interactions in the Basal Ganglia: 49 (Frontiers in Neuroscience)

CRC Press

£157.37 08 Mar 2026
The Glutamate Receptors (The Receptors)
95% match

The Glutamate Receptors (The Receptors)

Humana

£47.13 13 Jan 2026
Neurochemistry, Neuropharmacology and Behavior: Outlines on the mechanism of brain function
95% match

Neurochemistry, Neuropharmacology and Behavior: Outlines on the mechanism of brain function

VDM Verlag

£65.63 12 Mar 2026
Amines and Their Metabolites: 2 (Neuromethods, 2)
95% match

Amines and Their Metabolites: 2 (Neuromethods, 2)

Humana

£87.00 21 Feb 2026